WebOct 3, 2024 · These findings point the superiority of Myocardial Work for early type 1 CTRCD detection in comparison to the current diagnostic tools. Additionally, we suggest the add-on value of ΔWW on top of ΔGLS quantification for better patient risk stratification. These are promising results for better clinical surveillance of cardiac function during ... WebJul 21, 2024 · Background We investigated the usefulness of the left atrial (LA) strain measurement on the prediction of upcoming cancer therapeutics-related cardiac dysfunction (CTRCD) after trastuzumab therapy in patients with breast cancer who did not develop CTRCD after chemotherapy. Methods A total of 72 females with breast cancer …
Cardio-Oncology Echocardiography Protocol for …
WebJul 29, 2024 · Cancer therapy-related cardiac dysfunction (CTRCD) is one of the most feared and undesirable side effects of chemotherapy, occurring in approximately 10% of the patients. It can be classified as direct (dose-dependent vs dose-independent) or indirect, … WebCTRCD and presents evidence and consensus recommendations forcardiacevaluationofpatientsreceivingthistargetedtherapy,pri-marily indicated for HER2 … bin ghaith
Myocardial work analysis for early detection of type 1 CTRCD and ...
WebJul 26, 2024 · CTRCD remains a common referral in cardiology and cardio-oncology clinics. Therefore, it is essential that clinicians have thorough knowledge of the therapies … Web一般社団法人日本心エコー図学会 WebFeb 5, 2024 · Cancer-therapeutics-related cardiac dysfunction (CTRCD) is an important concern in women receiving trastuzumab therapy for HER2+ breast cancer. However, the ability to assess CTRCD risk remains limited. In this retrospective cohort study, we apply three published risk prediction models (Ezaz et al., … bing ha integrato chat gpt